Lake Street analyst Brooks O’Neil raised the firm’s price target on Electromed (ELMD) to $33 from $26 and keeps a Buy rating on the shares after the company posted “solid” Q1 results. The stock has done “extremely well” with a 141% year-to-date increase, but the firm believes there is “still room for multiple expansion given continued strong growth and solid execution,” the analyst tells investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks